Trending Topics
HARMONi-6 Demonstrates Significant Overall Survival Benefit (HR=0.66): Ivonescimab Plus Chemotherapy Superior to PD-1 Plus Chemotherapy in First-Line sq-NSCLC Landmark Results to Be Presented at ASCO 2026 Plenary Session
CHICAGO, May 31, 2026 /PRNewswire/ -- Akeso, Inc. (9926.HK) ("Akeso" or the "Company") today announced that ivonescimab, the Company's first-in-class PD-1/VEGF bispecific antibody, has achieved a statistically significant and clinically meaningful improvement in overall survival (OS) as a first-l...
Relief as Firmable locates 15,000 accounting decision-makers reported missing at leading global B2B data provider
Sydney-based sales team initiates platform support ticket after discovering significantly more contacts than expected. Investigation concludes that data is correct. MELBOURNE, Australia and SINGAPORE, May 31, 2026 /PRNewswire/ -- Firmable, Asia-Pacific's leading AI-native sales platform, has con...
AI: Digital to Physical | BEYOND Expo 2026 Leads Transformative Global Direction of Tech
MACAO, May 31, 2026 /PRNewswire/ -- The BEYOND Expo 2026 has shown what the future looks like as it delivers on its mission of 'Empowering Asia, Bridging the World' with a heavyweight showcase of the latest emerging technology and ideas from Asia. Held at The Venetian Cotai Expo with the theme "A...
Dizal Presents Positive NSCLC Data for Fourth-Generation EGFR TKI DZD6008 and Golidocitinib in Combination with Anti-PD-1 at ASCO 2026
* Oral presentation of DZD6008 demonstrated strong and durable anti-tumor activity, excellent BBB-penetrant properties, and a favorable safety profile in patients relapsed from third-generation EGFR TKI * In treatment-naïve patients with advanced NSCLC without driver mutations, Golidocitinib,...
Sacituzumab Tirumotecan (sac-TMT) in Combination with Pembrolizumab for First-Line Treatment of PD-L1-Positive NSCLC Published in The Lancet
CHENGDU, China, May 31, 2026 /PRNewswire/ -- Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (the "Company", 6990.HK) announced today that the results of the Phase III clinical study OptiTROP-Lung05, evaluating the company's trophoblast cell-surface antigen 2 (TROP2)-directed antibody drug con...
The Results of Phase III OptiTROP-Lung05 Study of Sacituzumab Tirumotecan (sac-TMT) Presented as an ASCO Oral Presentation and Simultaneously Published in The Lancet
CHENGDU, China, May 30, 2026 /PRNewswire/ -- Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (the "Company", 6990.HK) announced today that at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, the results of the Phase III clinical study OptiTROP-Lung05, evaluating...
Kelun-Biotech Presents Pivotal Phase II Data for Lunbotinib Fumarate (A400/EP0031) in RET Fusion-Positive NSCLC at 2026 ASCO
CHENGDU, China, May 30, 2026 /PRNewswire/ -- Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (the "Company", 6990.HK) announced that at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting held in Chicago, USA, results from the pivotal Phase II study of the Company's next-genera...
Creality Charts Next Decade as AI-Powered Consumer 3D Creative Platform, Hong Kong listing anchors the company's full-stack ecosystem shift
HONG KONG, May 30, 2026 /PRNewswire/ -- As an emerging segment at the intersection of intelligent manufacturing and creative consumption, the global consumer 3D printing industry has become one of the fastest-growing markets in consumer technology. According to China Insights Industry Consultancy...
OCI Global Q1 2026 Trading Update
AMSTERDAM, May 30, 2026 /PRNewswire/ -- Hassan Badrawi, CEO of OCI Global: "During the first quarter, OCI made continued progress in executing its strategic priorities, including the completion of the sale of OCI Ammonia Holding to AGROFERT, the handover of Beaumont New Ammonia to Woodside, and t...
Lanvin Names Barbara Werschine as CEO
SHANGHAI, May 29, 2026 /PRNewswire/ -- Lanvin Group (NYSE: LANV), a global luxury fashion group, today announced that Maison Lanvin, the oldest couture house in Paris, has appointed Barbara Werschine as Chief Executive Officer. Ms. Werschine is an accomplished leader in the international luxury s...
Lanvin Names Barbara Werschine as CEO
SHANGHAI, May 29, 2026 /PRNewswire/ -- Lanvin Group (NYSE: LANV), a global luxury fashion group, today announced that Maison Lanvin, the oldest couture house in Paris, has appointed Barbara Werschine as Chief Executive Officer. Ms. Werschine is an accomplished leader in the international luxury s...
Creality Marks 12 Years with KliTek™ and AI-Powered Ecosystem Expansion
SHENZHEN, China, May 29, 2026 /PRNewswire/ -- For 12 years, Creality, a global leader in consumer 3D printing, has advanced accessible 3D printing technologies, enabling global users to turn ideas into tangible creations. What began as a desktop 3D printer manufacturer has evolved into a global c...
AMTD's Successful Completion of Acquisition of The Ritz-Carlton, Perth, Valued at A$280 Million
PARIS and NEW YORK and LONDON, May 29, 2026 /PRNewswire/ -- AMTD Group Inc. ("AMTD Group"), AMTD IDEA Group (NYSE: AMTD; SGX: HKB), AMTD Digital Inc. (NYSE: HKD), and The Generation Essentials Group ("TGE", NYSE: TGE; LSE: TGE), a subsidiary of AMTD Digital Inc., (collectively, "AMTD") jointly an...
2026 VIETNAM ESG INVESTOR CONFERENCE: FROM MARKET SIGNALS TO PRACTICAL DIALOGUE: ESG TO BECOME THE "NEW FILTER" FOR INVESTMENT CAPITAL
HO CHI MINH CITY, Vietnam, May 29, 2026 /PRNewswire/ -- The 4th annual conference, 2026 Vietnam ESG Investor Conference,successfully took place on 26-27 May, 2026, at the New World Saigon Hotel, Ho Chi Minh City. With the participation of over 250 domestic and international delegates, the event ...
X Square Robot Open-Sources WALL-WM, Shifting Robot World Modeling From Chunks to Events
WALL-WM teaches robots to model meaningful physical events, not just fixed slices of time. For a robot, the physical world does not change in neat, fixed-length clips. A task may look continuous on camera, but the important moments are discrete: approaching an object, making contact, grasping it...
Acer Unveils Sub-1kg TravelMate P6 14 AI Business Laptop with New Acer Comfort Touch Design for Premium Luxury on the Move
Lineup also deploys new Intel Core Series 3 processors on business laptops for the first time across form factors Editor's Summary * The Acer TravelMate P6 14 AI is a Windows 11 Copilot+ PC powered by Intel Core Ultra Series 3 processors with Intel vPro, delivering 150 TOPS of platform AI pow...
Acer Introduces Predator Helios 18 AI: The Ultimate Gaming Laptop
Gaming lineup also includes the Acer Nitro 16 laptop, the Acer Nitro Blaze Link streaming handheld device, and accessories for leveling up gaming experiences Editor's Summary * Winner of the iF Design Award 2026, the Predator Helios 18 AI gaming laptop delivers ultimate performance with up to ...
Leading Korean Digital Contents Companies Target Global Market at CommunicAsia 2026 K-Digital Contents Pavilion
SINGAPORE and JINCHEON, South Korea, May 29, 2026 /PRNewswire/ -- The National IT Industry Promotion Agency (NIPA), a government-affiliated agency under Korea's Ministry of Science and ICT, will present the K-Digital Contents Pavilion at ATxSG CommunicAsia 2026, introducing seven promising Korean...
NYSE Content Update: Dell Technologies Reports 88% Revenue Increase YoY
NYSE issues a pre-market daily advisory direct from the trading floor. NEW YORK, May 29, 2026 /PRNewswire/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today's NYSE Pre-market update for market insights before trading begins...
Dizal Announces Phase 3 WU-KONG28 Results: ZEGFROVY® (Sunvozertinib) Outperforms Platinum-Doublet Chemotherapy in First-Line EGFR Exon 20 Insertion Mutation-Positive Non-Small Cell Lung Cancer
* ZEGFROVY® demonstrated superior anti-tumor efficacy compared to platinum-doublet chemotherapy as a first-line treatment for advanced NSCLC with EGFR exon20ins * WU-KONG28 is the first global randomized phase 3 study with positive results for an oral, chemo-free, targeted monotherapy regimen...
Week's Top Stories
Most Reposted
vVardis Raises $175 Million Ahead of NYSE IPO: NYSE Content Update
[Picked up by 1183 media titles]
2026-11-13 22:11
Cision Introduces AI-Powered Cision Intelligence to Help Brands See More and Act with Confidence
[Picked up by 1170 media titles]
2026-11-12 23:00
The NYSE Welcomes vVARDIS as a Publicly Listed Company
[Picked up by 1168 media titles]
2026-11-14 13:23
Cyient, 3-GIS Partner to Help Telecom and Utility Operators Turn Network Data into Operational Control
[Picked up by 1154 media titles]
2026-11-11 22:00Royal Bank of Canada announces agreement to acquire Yarra Capital Management
[Picked up by 1143 media titles]
2026-11-09 21:00Most Read
DomoAI Launches InkoAI Agent - One Sentence to Ready-to-Post Video
Royal Bank of Canada announces agreement to acquire Yarra Capital Management
Cision Report Reveals the Consumer Trends Hidden Between Search, Social, and AI
Poppi Founders Launch Hydration Brand jetty: NYSE Content Update
